DK1311284T3 - En ny specifik mekanisme til inhibering af blodpladeadhæsion til kollagen - Google Patents

En ny specifik mekanisme til inhibering af blodpladeadhæsion til kollagen

Info

Publication number
DK1311284T3
DK1311284T3 DK01976139T DK01976139T DK1311284T3 DK 1311284 T3 DK1311284 T3 DK 1311284T3 DK 01976139 T DK01976139 T DK 01976139T DK 01976139 T DK01976139 T DK 01976139T DK 1311284 T3 DK1311284 T3 DK 1311284T3
Authority
DK
Denmark
Prior art keywords
collagen
platelet adhesion
specific mechanism
new specific
inhibiting platelet
Prior art date
Application number
DK01976139T
Other languages
Danish (da)
English (en)
Inventor
Uwe Hofmann
Matthias Frech
Christopher Barnes
Johannes Gleitz
Wolfgang Strittmatter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1311284T3 publication Critical patent/DK1311284T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
DK01976139T 2000-08-25 2001-08-23 En ny specifik mekanisme til inhibering af blodpladeadhæsion til kollagen DK1311284T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00118542 2000-08-25
PCT/EP2001/009746 WO2002015919A2 (en) 2000-08-25 2001-08-23 Saratin for inhibiting platelet adhesion to collagen

Publications (1)

Publication Number Publication Date
DK1311284T3 true DK1311284T3 (da) 2005-04-18

Family

ID=8169664

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01976139T DK1311284T3 (da) 2000-08-25 2001-08-23 En ny specifik mekanisme til inhibering af blodpladeadhæsion til kollagen

Country Status (27)

Country Link
US (2) US6881722B2 (xx)
EP (1) EP1311284B1 (xx)
JP (1) JP4988131B2 (xx)
KR (1) KR100794277B1 (xx)
CN (1) CN1224421C (xx)
AR (1) AR030492A1 (xx)
AT (1) ATE285246T1 (xx)
AU (2) AU9550601A (xx)
BR (1) BR0113478A (xx)
CA (1) CA2419385C (xx)
CZ (1) CZ302353B6 (xx)
DE (1) DE60107962T2 (xx)
DK (1) DK1311284T3 (xx)
EC (1) ECSP034485A (xx)
ES (1) ES2234896T3 (xx)
HK (1) HK1059736A1 (xx)
HU (1) HU229367B1 (xx)
MX (1) MXPA03001604A (xx)
MY (1) MY128992A (xx)
NO (1) NO331326B1 (xx)
PT (1) PT1311284E (xx)
RU (1) RU2302880C2 (xx)
SI (1) SI1311284T1 (xx)
SK (1) SK287829B6 (xx)
UA (1) UA77402C2 (xx)
WO (1) WO2002015919A2 (xx)
ZA (1) ZA200302296B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056885A1 (en) * 1999-03-18 2000-09-28 Merck Patent Gmbh Protein for blocking platelet adhesion
WO2004062551A2 (en) 2003-01-10 2004-07-29 Ablynx N.V. RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
WO2007038749A2 (en) * 2005-09-28 2007-04-05 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
US20080069774A1 (en) * 2005-11-17 2008-03-20 Lance Liotta Proteomic antisense molecular shield and targeting
CN117229423B (zh) * 2023-11-10 2024-02-06 北京科技大学 一种用于结合胶原的多肽纳米材料及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947401A (en) * 1971-10-05 1976-03-30 Union Optics Corporation Hydrogels of unsaturated ester copolymers
US5705355A (en) 1984-03-27 1998-01-06 Transgene, S.A. Hirudin, pharmaceutical compositions comprising it and their use
US4898734A (en) * 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
IL86857A (en) * 1988-06-24 1994-04-12 Yissum Res Dev Co Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
US5304121A (en) * 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
CA2052486A1 (en) * 1990-10-09 1992-04-10 Thomas M. Connolly Protein for inhibiting collagen-stimulated platelet aggregation
GB9022040D0 (en) 1990-10-10 1990-11-21 Biopharm Ltd Platelet adhesion inhibitor
US5179082A (en) * 1990-11-13 1993-01-12 Merck & Co., Inc. Method for blocking platelet adhesion to collagen
DE4136513A1 (de) 1991-11-06 1993-05-13 Basf Ag Neues thrombininhibitorisches protein aus raubwanzen
AU680929B2 (en) * 1993-07-01 1997-08-14 Merck Patent Gmbh Inhibitor of collagen-stimulated platelet aggregation
DK1118325T4 (da) * 1993-07-29 2010-04-06 Us Health Anvendelse af paclitaxel og dets derivater ved fremstilling af et medikament til behandling af restenose
US5532287A (en) * 1994-05-04 1996-07-02 Ciba-Geigy Corporation Radiation cured drug release controlling membrane
US6246715B1 (en) * 1998-06-26 2001-06-12 Samsung Electronics Co., Ltd. Data transmitter and receiver of a DS-CDMA communication system
US5843172A (en) * 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
AU772460B2 (en) * 1998-10-16 2004-04-29 Immunex Corporation Inhibitors of platelet activation and recruitment
IT1304135B1 (it) * 1998-11-26 2001-03-07 Magneti Marelli Spa Metodo di controllo dell' iniezione e dell' accensione in un motoreendotermico ad iniezione diretta per accelerare il riscaldamento del
EP1382345A3 (en) * 1999-02-19 2004-01-28 Zymogenetics Inc Uses of inhibitors of hemostasis
WO2000056885A1 (en) 1999-03-18 2000-09-28 Merck Patent Gmbh Protein for blocking platelet adhesion

Also Published As

Publication number Publication date
US20050143305A1 (en) 2005-06-30
ECSP034485A (es) 2003-03-31
ES2234896T3 (es) 2005-07-01
HK1059736A1 (en) 2004-07-16
JP2004506690A (ja) 2004-03-04
SK287829B6 (sk) 2011-11-04
HUP0303747A3 (en) 2006-01-30
SK3132003A3 (en) 2003-08-05
US6881722B2 (en) 2005-04-19
WO2002015919A3 (en) 2002-05-30
US20030190342A1 (en) 2003-10-09
MXPA03001604A (es) 2003-06-04
DE60107962T2 (de) 2005-12-15
NO20030841D0 (no) 2003-02-24
CN1224421C (zh) 2005-10-26
NO20030841L (no) 2003-02-24
NO331326B1 (no) 2011-11-28
CA2419385C (en) 2011-05-10
HU229367B1 (en) 2013-11-28
AU2001295506B2 (en) 2007-02-15
EP1311284B1 (en) 2004-12-22
CZ2003720A3 (cs) 2003-06-18
AU9550601A (en) 2002-03-04
ATE285246T1 (de) 2005-01-15
DE60107962D1 (de) 2005-01-27
HUP0303747A2 (hu) 2004-03-01
RU2302880C2 (ru) 2007-07-20
WO2002015919A2 (en) 2002-02-28
SI1311284T1 (xx) 2005-08-31
JP4988131B2 (ja) 2012-08-01
PL359246A1 (en) 2004-08-23
KR20030034141A (ko) 2003-05-01
US7459438B2 (en) 2008-12-02
PT1311284E (pt) 2005-05-31
UA77402C2 (en) 2006-12-15
BR0113478A (pt) 2003-07-15
CZ302353B6 (cs) 2011-03-30
CN1449291A (zh) 2003-10-15
CA2419385A1 (en) 2002-02-28
MY128992A (en) 2007-03-30
KR100794277B1 (ko) 2008-01-11
EP1311284A2 (en) 2003-05-21
AR030492A1 (es) 2003-08-20
ZA200302296B (en) 2004-06-30

Similar Documents

Publication Publication Date Title
DK1161530T3 (da) Protein til blokering af blodpladeadhæsion
FI20000090A0 (fi) Signalointimenetelmä
DE60112811D1 (de) Neue photochrome indenonaphthopyranverbindungen
CY2004011I1 (el) Aσυμμετρη συνθεση της πρεγαβαλινης
DE60108825D1 (de) Regenerierte harzzusammensetzung
DE60106823D1 (de) Motorrad
AR027983A1 (es) Novedosos compuestos
DE60131992D1 (de) Pfropfcopolymere enthaltende klebstoffe
DE60108453D1 (de) Motorrad
DK1132568T3 (da) Tætning af en sideboring
NO20023261D0 (no) Småbok
DK1311284T3 (da) En ny specifik mekanisme til inhibering af blodpladeadhæsion til kollagen
IS6657A (is) Ný efnasambönd
AR028220A1 (es) Novedosos compuestos
DE50102391D1 (de) Schalter für ein Fahrrad
DK1300160T3 (da) Fremgangsmåde til stabilisering af en sammensætning
DE60031109D1 (de) Übertragsicherstellungsaddierer
DE60120063D1 (de) Kassettenbehälter
DE60025935D1 (de) Styrolharzzusammensetzung
DE50103295D1 (de) Klebstoffkartusche
AR028399A1 (es) Nuevos compuestos
DE60132509D1 (de) Stopuhr
IT1315012B1 (it) Microabrasore a ghiaccio
DK1253917T3 (da) Anvendelse af substituerede 4-amino-1-phenylbutan-2-ol-forbindelser som lægemiddel
NO20000741D0 (no) Anordning ved mærkonstruksjon